Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 2
Submit an article Journal homepage
1,748
Views
2
CrossRef citations to date
0
Altmetric
Immunotherapy - Other

Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)

Kathryn Klinea University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;b Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USAView further author information
,
Wengen Chenc Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USAView further author information
,
Michael E. Kallend Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USAView further author information
,
Rima Kokad Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USAView further author information
,
Destiny Omilia University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information
,
Xiaoxuan Fana University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;f Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USAView further author information
,
Thierry Iraguhaa University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information
,
Etse Gebrua University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information
,
Nishanthini Dishanthana University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information
,
Jillian M. Bakerf Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USAView further author information
,
Kenneth A. Dietzef Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USAView further author information
,
Jean A. Yareda University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;b Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information
,
Kim Hankeya University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;b Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USAView further author information
,
Saurabh Dahiyaa University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;b Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;g Blood and Marrow Transplant Program, Stanford University, Stanford, CA, USAView further author information
,
Silke V. Niederhaush Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USAView further author information
,
Kieron Dunleavyi Hematology Program, George Washington University, Washington, DC, USAView further author information
,
Nancy M. Hardya University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;b Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information
,
Tim Luetkensa University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;f Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USAView further author information
,
Aaron P. Rapoporta University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;b Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information
&
Djordje Atanackovica University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;b Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA;e Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA;f Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USACorrespondence[email protected]
View further author information
 show all
Article: 2216116 | Received 29 Mar 2023, Accepted 17 May 2023, Published online: 06 Jun 2023

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.